drugset / Trial / NCT01000896
Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to explore the safety and tolerability of AZD0530 in combination with carboplatin and paclitaxel in Japanese patients with non small cell lung cancer and epithelial ovarian cancer.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-09
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | saracatinib | Small molecule | — | Oral |
| Background | Carboplatin | Small molecule | — | Intravenous |
| Background | Paclitaxel | Small molecule | — | Intravenous |